Fil LTD Krystal Biotech, Inc. Transaction History

Fil LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$52.01 - $71.77 $9.2 Million - $12.7 Million	-176,799 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$62.14 - $81.82 $53,751 - $70,774	865 Added 0.49%	176,799 $12 Million
Q1 2021 May 14, 2021	SELL	$59.42 - $85.46 $3.89 Million - $5.59 Million	-65,392 Reduced 27.1%	175,934 $13.6 Million
Q4 2020 Feb 08, 2021	BUY	$40.64 - $61.38 $7.33 Million - $11.1 Million	180,350 Added 295.77%	241,326 $14.5 Million
Q3 2020 Nov 13, 2020	BUY	$37.76 - $48.49 $2,869 - $3,685	76 Added 0.12%	60,976 $2.63 Million
Q2 2020 Aug 13, 2020	BUY	$37.03 - $60.0 $2.26 Million - $3.65 Million	60,900 New	60,900 $2.52 Million

300

24.3M

388K

233K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.84B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.